TSMC & Morgan Stanley Rise; Goldman & Boston Scientific Fall

User profile image

TrustFinance Global Insights

1월 15, 2026

2 min read

5

TSMC & Morgan Stanley Rise; Goldman & Boston Scientific Fall

Premarket Movers Signal Mixed Sector Performance

U.S. stock futures indicated a mixed open as investors processed key corporate earnings reports from the banking, technology, and healthcare sectors. Technology shares showed notable strength, while some financial and medical device stocks faced headwinds from earnings details and acquisition news.

Overview of Key Stock Movements

Taiwan Semiconductor Manufacturing (TSM) shares surged 6.2% after the chipmaker reported fourth-quarter profits that surpassed analyst expectations, driven by high demand for artificial intelligence technology. In the financial sector, Morgan Stanley (MS) rose 1.1% on a reported increase in quarterly profit. Conversely, Goldman Sachs (GS) stock declined 1.4% despite its own profit growth. Boston Scientific (BSX) saw its stock fall 3.5% after announcing its intention to acquire Penumbra for approximately $14.5 billion.

Sector-Specific Impacts

The premarket activity highlights distinct trends across industries. TSMC's strong performance reinforces the ongoing investor enthusiasm for AI-related stocks. The divergent results from investment banks suggest a complex recovery in dealmaking. Meanwhile, the negative reaction to Boston Scientific's deal indicates market scrutiny of large-scale corporate acquisitions.

Summary and Outlook

The market continues to be driven by company-specific fundamentals. Investors will likely keep a close watch on earnings from technology leaders and financial institutions to gauge the health of the broader economy.

FAQ

Q: Why did TSMC stock increase significantly?
A: TSMC stock rose 6.2% due to stronger-than-expected fourth-quarter net profit, which was largely fueled by substantial demand for its artificial intelligence chips.

Q: What caused Boston Scientific's stock to decline?
A: Boston Scientific's stock fell 3.5% following the company's announcement of its plan to acquire Penumbra in a deal valued at about $14.5 billion.

Source: Investing.com

Written by

User profile image

TrustFinance Global Insights

AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.